Johnson & Johnson (JNJ/NYSE): general review

The shares of Johnson & Johnson have been strengthening since the beginning of July and are now trading near the May highs at USD 127.42. On July 17, before the market opens, the company will report for Q2 2018. In Q1 2018, pharmaceutical sales increased by 19% YoY.